Sponsors (6)
The bill strengthens federal standards and enforcement to reduce opioid contamination in poppy-seed foods and prevent diversion—improving public health and regulatory certainty—but imposes new costs, supply risks, and potential justice consequences for producers, sellers, and unknowingly affected consumers.
Consumers and patients: clearer federal contamination limits will reduce opioid residues in poppy-seed foods, lowering accidental opioid exposures, hospitalizations, false-positive drug tests, and deaths.
Regulators and prosecutors: the bill clarifies that contaminated (unwashed) poppy seeds are subject to federal control and clarifies HHS/DEA authority, improving enforcement certainty and enabling removal of adulterated products from interstate commerce.
Bakers and food manufacturers: a uniform federal standard creates consistent compliance criteria across states and suppliers, reducing regulatory fragmentation and simplifying interstate compliance.
Small businesses, farmers, and seed suppliers: new contamination limits will drive testing and compliance costs, raise the risk of recalls or seized shipments, and could force some suppliers or processors out of the market.
Consumers and middle-class families: reduced supply or supplier withdrawals (or effectively banned imports/lots if limits are very low) could raise prices and make poppy-seed products harder to find.
Individuals who unknowingly consume contaminated poppy seeds: treating contaminated seeds as controlled substances risks criminal or administrative consequences (including implications for employment or military drug testing) for people who ingest adulterated food unknowingly.
Based on analysis of 4 sections of legislative text.
Requires HHS/FDA to set contamination limits for morphine, codeine, thebaine, and other alkaloids in poppy seeds and deems seeds exceeding those limits adulterated and banned in interstate commerce.
Official title: To prohibit the sale of food that is, or contains, unsafe poppy seeds.
Introduced April 2, 2025 by Steve Womack · Last progress April 2, 2025
Requires HHS (acting through FDA) to write rules that set numeric or other limits for morphine, codeine, thebaine, and other alkaloid contaminants in poppy seeds and declares seeds exceeding those limits to be adulterated and prohibited in interstate commerce. It also makes clear that poppy seeds contaminated above those limits remain subject to the Controlled Substances Act. Sets deadlines for rulemaking (proposed rule within 1 year, final within 2 years) and preserves federal controlled-substance authority over contaminated seeds, with the goal of preventing deaths and harms linked to morphine-contaminated poppy seed products.